Works matching IS 0741238X AND DT 2025 AND VI 42 AND IP 2
Results: 40
Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1265, doi. 10.1007/s12325-024-03094-3
- By:
- Publication type:
- Article
Randomised, Placebo-Controlled, Double-Blind Trial to Assess Efficacy and Safety of ELOM-080 in Outpatients with COVID-19.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1237, doi. 10.1007/s12325-024-03093-4
- By:
- Publication type:
- Article
Simplified Approach to Managing Newly Diagnosed Patients with Mild-to-Moderate Hypertension in Routine Clinical Practice.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1108, doi. 10.1007/s12325-024-03091-6
- By:
- Publication type:
- Article
CKD-Associated Pruritus is Associated with Greater Use of Antidepressants and Anti-pruritus Medications.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1283, doi. 10.1007/s12325-024-03090-7
- By:
- Publication type:
- Article
Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1131, doi. 10.1007/s12325-024-03088-1
- By:
- Publication type:
- Article
Understanding MASH: An Examination of Progression and Clinical Outcomes by Disease Severity in the TARGET-NASH Database.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1165, doi. 10.1007/s12325-024-03085-4
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Finerenone for Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes from Japanese Payer Perspective.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 995, doi. 10.1007/s12325-024-03084-5
- By:
- Publication type:
- Article
Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI).
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1061, doi. 10.1007/s12325-024-03083-6
- By:
- Publication type:
- Article
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 904, doi. 10.1007/s12325-024-03082-7
- By:
- Publication type:
- Article
The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's Disease.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1044, doi. 10.1007/s12325-024-03081-8
- By:
- Publication type:
- Article
Real-World Safety, Tolerability and Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Final Report of Post-marketing Surveillance in Japan.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1075, doi. 10.1007/s12325-024-03079-2
- By:
- Publication type:
- Article
Trifluridine/Tipiracil (FTD/TPI) in Metastatic Colorectal Cancer in Hong Kong: A Territory-Wide Cohort Study.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1222, doi. 10.1007/s12325-024-03077-4
- By:
- Publication type:
- Article
An Access-Focused Patient-Centric Value Assessment Framework for Medication Formulary Decision-Making in Immune-Mediated Inflammatory Diseases.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 568, doi. 10.1007/s12325-024-03076-5
- By:
- Publication type:
- Article
Real-World Effectiveness of Long-Acting Injectable and Oral Antipsychotic Agents in US Medicare Patients with Schizophrenia.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1251, doi. 10.1007/s12325-024-03075-6
- By:
- Publication type:
- Article
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 886, doi. 10.1007/s12325-024-03074-7
- By:
- Publication type:
- Article
Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1147, doi. 10.1007/s12325-024-03073-8
- By:
- Publication type:
- Article
Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 918, doi. 10.1007/s12325-024-03072-9
- By:
- Publication type:
- Article
Costs of Oral Corticosteroid Use in Patients with Severe Asthma With/Without Chronic Rhinosinusitis with Nasal Polyps: Data from the Italian SANI Registry.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1196, doi. 10.1007/s12325-024-03071-w
- By:
- Publication type:
- Article
Clinical Features and Current Pharmacotherapy of OAB in Practice: Ideal and Reality.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1094, doi. 10.1007/s12325-024-03070-x
- By:
- Publication type:
- Article
An Indirect Treatment Comparison of Lenvatinib for the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 977, doi. 10.1007/s12325-024-03068-5
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, Bioavailability, and Immunogenicity of Obexelimab Following Subcutaneous Administration in Healthy Japanese and Non-Japanese Volunteers.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 813, doi. 10.1007/s12325-024-03067-6
- By:
- Publication type:
- Article
Genetic Etiologies and Outcomes in Malignancy and Mortality in Activated Phosphoinositide 3-Kinase Delta Syndrome: A Systematic Review.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 752, doi. 10.1007/s12325-024-03066-7
- By:
- Publication type:
- Article
Content Validation of the QOL-B-RD and PROMIS-F SF-7a to Measure Respiratory and Fatigue Symptoms of MAC Lung Disease.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 935, doi. 10.1007/s12325-024-03064-9
- By:
- Publication type:
- Article
US Real-World Effectiveness, Tolerability, and Healthcare Resource Utilization After Addition of Fremanezumab for Preventive Treatment in Patients Using Gepants for Acute Treatment of Migraine: Results From a Retrospective Chart Review.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1207, doi. 10.1007/s12325-024-03063-w
- By:
- Publication type:
- Article
Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 579, doi. 10.1007/s12325-024-03062-x
- By:
- Publication type:
- Article
Machine Learning Applications in Acute Coronary Syndrome: Diagnosis, Outcomes and Management.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 636, doi. 10.1007/s12325-024-03060-z
- By:
- Publication type:
- Article
Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2–4 Years with Rett Syndrome.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1009, doi. 10.1007/s12325-024-03058-7
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling to Support Trofinetide Dosing for the Treatment of Rett Syndrome.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 1026, doi. 10.1007/s12325-024-03056-9
- By:
- Publication type:
- Article
Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 830, doi. 10.1007/s12325-024-03055-w
- By:
- Publication type:
- Article
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 849, doi. 10.1007/s12325-024-03051-0
- By:
- Publication type:
- Article
One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 720, doi. 10.1007/s12325-024-03049-8
- By:
- Publication type:
- Article
Addressing the Human Experience of Chronic Kidney Disease: A Call to Transform Kidney Care.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 559, doi. 10.1007/s12325-024-03048-9
- By:
- Publication type:
- Article
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 666, doi. 10.1007/s12325-024-03043-0
- By:
- Publication type:
- Article
Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 734, doi. 10.1007/s12325-024-03042-1
- By:
- Publication type:
- Article
Effects of Current Therapies on Disease Progression in Fabry Disease: A Narrative Review for Better Patient Management in Clinical Practice.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 597, doi. 10.1007/s12325-024-03041-2
- By:
- Publication type:
- Article
Correction to: Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle Cell Disease in the United States and United Kingdom: Qualitative Assessment of Health-Related Quality of Life Impacts Associated with Sickle...: J. Drahos et al.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 863, doi. 10.1007/s12325-024-03038-x
- By:
- Publication type:
- Article
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized Trial.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 801, doi. 10.1007/s12325-024-03037-y
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 788, doi. 10.1007/s12325-024-03000-x
- By:
- Publication type:
- Article
A Pharmacoeconomic Study of Post-Exposure Prophylaxis Strategies for Influenza Virus Infections in Japan.
- Published in:
- Advances in Therapy, 2025, v. 42, n. 2, p. 772, doi. 10.1007/s12325-024-02988-6
- By:
- Publication type:
- Article